Medifast layoffs, on the record
Every job cut, severance charge and restructuring Medifast reported in its annual reports, 2023 to 2025, quoted from the filings.
Job cuts, severance and restructuring
Our summaryRestructuring of certain external manufacturing agreements, with expenses excluded from non-GAAP cost of sales and gross profit for 2022.
Word for word“Non-GAAP adjusted cost of sales excludes expenses in connection with the restructuring of certain external manufacturing agreements of $12.2 million for 2022.” 10-K for 2023
Our summaryCompany recorded supply chain optimization charges, including accelerated depreciation and impairment of equipment, and excluded restructuring costs of external manufacturing agreements from non-GAAP cost of sales.
Word for word“Non-GAAP adjusted cost of sales excludes expenses in connection with the restructuring of certain external manufacturing agreements.” 10-K for 2024
Our summaryCompany recorded one-time severance costs as part of its supply chain optimization charges.
Word for word“Non-cash charges for supply chain optimization 11,689 One-time severance costs 813 Total supply chain optimization $ 12,502” 10-K for 2024
Our summaryMedifast reported a net decrease in employee compensation in 2025 from realigning its employee base to lower revenue levels, partly offset by one-time restructuring charges.
Word for word“Selling, general and administrative: Selling, general and administrative (“SG&A”) expenses were $289.4 million in 2025, a decrease of $152.3 million, or 34.5%, as compared to $441.7 million in 2024, primarily due to a $85.1 million decrease in 35 Table of Contents coach compensation due to lower sales volumes and a decrease in the number of active earning coaches, a $13.4 million decrease in company-led marketing related expenses, a $12.5 million decrease for supply chain optimization that did not recur in 2025, a $9.3 million net decrease in employee compensation resulting from the realignment of the employee base to lower revenue levels partially offset by one-time restructuring charges, a $7.5 million decrease for medically supported weight loss expenses that did not recur in 2025, and a $5.7 million decrease in coach event costs.” 10-K for 2025
| Fiscal year ended | Severance costs | Restructuring charges | Cash paid for restructuring |
|---|---|---|---|
| 2016-12-31 | — | $1.3 million | $997,000 |
| 2017-12-31 | — | — | $346,000 |
| 2024-12-31 | $813,000 | — | — |
Medifast has filed no restructuring notice (Form 8-K, Item 2.05) since 2016. Companies file one only for a cut they judge material, so many announced layoffs never appear as one. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Medifast’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-17. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.